Compounds > fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether
Page last updated: 2024-08-26

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Peripheral Nervous System Diseases

fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Peripheral Nervous System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eger, EI; Goldberg, ME; Larijani, GE1

Other Studies

1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Peripheral Nervous System Diseases

ArticleYear
Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MAC sevoflurane for 8 hours.
    Pharmacotherapy, 1999, Volume: 19, Issue:10

    Topics: Adult; Anesthesia; Anesthetics, Inhalation; Ethers; Humans; Hydrocarbons, Fluorinated; Male; Methyl Ethers; Peripheral Nervous System Diseases; Sevoflurane; Time Factors

1999